Revenue segments as reported by the company.

Smokeable Products

Oral Tobacco Products

Wine

All Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Marketing, administration and research costs

Asset impairment and exit costs

Amortization of intangibles

General corporate expenses

Corporate asset impairment and exit costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Altria

Altria Group, Inc. operates as a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral tobacco products, and Wine. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral tobacco products segment is primarily moist smokeless tobacco products (MSTs) through brands like Copenhagen and Skoal as well as on! oral nicotine pouches sold by Helix. The Wine segment, through subsidiary Ste. Michelle Wine Estates Ltd, produces Washington State wines, primarily Chateau Ste. Michelle and 14 Hands, and owns wineries in or distributes wines from several other wine regions. The company was founded in 1919 and is headquartered in Richmond, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Altria reports robust Q4 earnings, focuses on innovation and growth

Altria's Q4 2022 performance reflects resilience amidst industry challenges, with a focus on innovation and shareholder returns. The company's strategic initiatives in smoke-free products and digital engagement underscore its commitment to long-term growth and harm reduction.

Altria reports resilient Q1 performance amid industry challenges and opportunities

Altria's Q1 2023 earnings call highlighted strong performance amidst industry challenges, emphasizing harm reduction and regulatory compliance. The company faces hurdles from inflation, regulatory changes, and evolving consumer behaviors, while focusing on growth opportunities in smoke-free products and strategic investments.

Altria reports solid Q2 earnings, eyes e-vapor growth opportunities

Altria's focus on smoke-free products and NJOY acquisition driving growth.
Challenges in the cigarette industry due to economic pressures and flavor bans.
Opportunities in the e-vapor category and expansion plans in the U.S.
Strong balance sheet and significant capital returns to shareholders.

Altria reports growth in earnings, navigates regulatory challenges in e-vapor

Altria's Q3 2023 earnings call highlighted solid financial performance, strategic focus on e-vapor products, and efforts to combat illegal vape products. The company faces challenges from regulatory uncertainties and illicit products but sees opportunities in expanding NJOY's reach and addressing market gaps.

Altria reports growth in smoke-free products amidst regulatory challenges

Altria's Q4 2023 earnings call highlighted growth in adjusted EPS, strategic focus on smoke-free products, and efforts to combat illicit e-vapor products. The company faces challenges in competitive segments and economic pressures but sees opportunities in new product introductions and regulatory collaborations.

Altria reports mixed Q1 performance, focuses on growth strategies

Altria's Q1 performance showed growth in NJOY and oral tobacco segments, with challenges in EPS decline and economic pressures on consumers.
Strengths include reaffirmed EPS guidance, strategic investments, and focus on combating illicit e-vapor products.
Opportunities lie in maximizing profitability in oral tobacco, product positioning, and capturing transitioning consumers.
Overall, Altria's performance reflects a mix of growth, challenges, and strategic opportunities in navigating market dynamics.

Altria's NJOY drives growth as company navigates e-vapor challenges

Altria's Q2 2024 earnings call showcased strong performance in smoke-free products, highlighting growth in retail share and volume momentum. Despite challenges in the e-vapor category, the company remains focused on responsible regulation and enforcement. With a commitment to shareholder value and long-term growth strategies, Altria is poised for continued success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

"It's a moral position. I'm not predicting" the stock goes to zero, says Josh Brown, CEO of Ritholtz Wealth Management.

Josh Brown: I hope tobacco giant Altria's stock 'goes to zero'

Philip Morris

The chief executive of e-cigarette maker Juul stepped down on Wednesday as merger talks between its biggest investor Altria and Philip Morris collapsed in the face of a regulatory backlash against vaping that could reshape the industry.

Juul boss exits in vaping crisis as Philip Morris, Altria axe merger talks

The MO-PM merger talks have ended, the merger is off.

The Altria-Philip Morris Merger Is Off: Now What?

Altria Group Inc. (NYSE: MO) and Philip Morris International Inc. (NYSE: PM) saw their shares moving in opposite directions after the companies announced that their merger discussions have ended and that they will no longer be pursuing a merger.

Altria’s Plans Go Up in Smoke

Altria: Certain Wealth In Uncertain Times

The chief executive of e-cigarette maker Juul stepped down on Wednesday, with his company beset by a regulatory backlash against vaping, and merger talks between its biggest investor Altria and Philip Morris collapsed.

Juul boss exits in vaping crisis as Philip Morris, Altria end merger talks

This is a "pivotal moment" for the vaping industry, Altria CEO Howard Willard said in a speech Wednesday at the Global Tobacco & Nicotine Forum.

Altria CEO says vaping industry is at 'pivotal moment' as it fends off onslaught of public backlash

Tobacco giants Philip Morris International  and Altria Group  have scrapped merger talks as Altria-backed e-cigarette maker Juul Labs sank deeper into crisis and said it would suspend advertising in the United States.

Philip Morris and Altria ditch merger talks as Juul faces crisis

Philip Morris International has abandoned merger talks with Altria Group and will instead focus on the launch of its tobacco heating product iQOS in the United States, the company said on Wednesday. “After much deliberation, the companies have agreed to focus on launching iQOS in the US as part of their mutual interest to achieve.

Philip Morris, Altria call off merger talks

Philip Morris International  has scrapped merger talks with Altria Group  and will instead focus on the launch of its tobacco-heating product iQOS in the United States, the company said on Wednesday.

Philip Morris and Altria ditch merger talks amid vaping crackdown

The merger was called off as regulation around vaping in the U.S. ramps up.

Philip Morris International And Altria Call Off $200 Billion Merger

Juul Labs said Chief Executive Officer Kevin Burns will step down, as the highly valued private e-cigarette company confronts a growing public backlash.
The post Philip Morris, Altria End Merger Talks As Juul CEO Steps Down appeared first on Investor's Business Daily.

Philip Morris, Altria End Merger Talks As Juul CEO Steps Down

The best time to buy quality high-yield blue chips is when the market hates them most due to peak fear, uncertainty and doubt.

5 Reasons The Altria/Philip Morris Merger Could Be The High-Yield Buying Opportunity Of The Decade

Philip Morris International Inc  has abandoned merger talks with Altria Group Inc  and will instead focus on the launch of its tobacco heating product iQOS in the United States, the company said on Wednesday.

Philip Morris / Altria call off merger talks

Tobacco giants Altria and Philp Morris, which were once one company, have ended their discussions to reunite in a colossal merger that could have been worth more than $200 billion.

Altria and Philip Morris end plans to reunite

Altria Group, Inc. (NYSE: MO) and Philip Morris International Inc. (NYSE: PM) have ended merger discussions with Altria providing a statement on Juul leadership change and tightening 2019 full-year earnings guidance.

Altria, Philip Morris End Merger Talks

Philip Morris International Inc. PM, +1.03% and Altria Group Inc. MO, -0.37% said Wednesday they are ending their merger talks and will instead focus on launching IQOS in the U.S.

Philip Morris stock soars 6% premarket on news it has ended merger talks with Altria

Merger discussions between Philip Morris International and Altria have ended, PMI announced Wednesday morning.

Philip Morris & Altria end merger talks

Altria has been faced with a level of uncertainty recently surrounding a possible merger with PM, as well as negative headlines regarding its stake in e-cigarette leader JUUL.

Altria Up In Smoke

After Philip Morris was spun off from Altria in 2008, it has successfully grown its business at a much faster rate than its former parent. Though both companies offer similar products, what distinguishes them is the size and geographic presence.

Before The Mega Merger: Here’s A Look At How Philip Morris Stands In Comparison To Altria

The vaping leader is reportedly being investigated by federal prosecutors.

Juul Labs Faces New Criminal Probe

The most recent leg of Altria's sell-off has pushed the dividend yield up to 8.13%.

Altria: This Aristocrat Yields 8% And Is Trading With Its Lowest Valuation In Over A Decade

Altria got a bit of good news on Friday, with Bank of America Merrill Lynch reiterating its buy rating on the stock.

A Warning Flag For Altria

They're often not good deals for investors, and the SEC urges caution with them.

4 Reasons You Should Reject a Mini-Tender Offer for Altria

The leading e-cigarette maker generates most of its money from flavored pods.

News for Altria Stock (MO)